5/9
07:06 am
adpt
Adaptive Biotechnologies First Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Medium
Report
Adaptive Biotechnologies First Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
5/8
12:29 pm
adpt
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/7
09:13 pm
adpt
Compared to Estimates, Adaptive Biotechnologies (ADPT) Q1 Earnings: A Look at Key Metrics [Yahoo! Finance]
Low
Report
Compared to Estimates, Adaptive Biotechnologies (ADPT) Q1 Earnings: A Look at Key Metrics [Yahoo! Finance]
5/7
07:13 pm
adpt
Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Misses Revenue Estimates [Yahoo! Finance]
Low
Report
Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Misses Revenue Estimates [Yahoo! Finance]
5/7
04:19 pm
adpt
Adaptive Biotechnologies Reports First Quarter 2024 Financial Results [Yahoo! Finance]
Low
Report
Adaptive Biotechnologies Reports First Quarter 2024 Financial Results [Yahoo! Finance]
5/7
04:05 pm
adpt
Adaptive Biotechnologies Reports First Quarter 2024 Financial Results
Low
Report
Adaptive Biotechnologies Reports First Quarter 2024 Financial Results
5/3
05:42 am
adpt
Global Minimal Residual Disease Testing Market Projected to Surpass US$ 5.1 Billion by 2032, Driven by Technological Advancements, & Clinical Applications and End-User Engagement [Yahoo! Finance]
Medium
Report
Global Minimal Residual Disease Testing Market Projected to Surpass US$ 5.1 Billion by 2032, Driven by Technological Advancements, & Clinical Applications and End-User Engagement [Yahoo! Finance]
4/17
04:05 pm
adpt
Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024
Medium
Report
Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024
4/4
12:33 pm
adpt
Adaptive Biotechnologies Co. (NASDAQ: ADPT) had its price target lowered by analysts at BTIG Research from $6.00 to $5.00. They now have a "buy" rating on the stock.
Medium
Report
Adaptive Biotechnologies Co. (NASDAQ: ADPT) had its price target lowered by analysts at BTIG Research from $6.00 to $5.00. They now have a "buy" rating on the stock.
4/2
04:24 pm
adpt
Adaptive Biotechnologies announces conclusion of strategic review, expects Q1 revenue between $41M and $43M [Seeking Alpha]
High
Report
Adaptive Biotechnologies announces conclusion of strategic review, expects Q1 revenue between $41M and $43M [Seeking Alpha]
4/2
04:17 pm
adpt
Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue [Yahoo! Finance]
High
Report
Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue [Yahoo! Finance]
4/2
04:05 pm
adpt
Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue
Medium
Report
Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue
3/27
08:30 am
adpt
Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024
Low
Report
Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024
3/14
09:26 am
adpt
SWEETWATER PRIVATE EQUITY HONORS GEOFFREY CHAIKEN, CO-FOUNDER AND CEO OF BLINK HEALTH [Yahoo! Finance]
Low
Report
SWEETWATER PRIVATE EQUITY HONORS GEOFFREY CHAIKEN, CO-FOUNDER AND CEO OF BLINK HEALTH [Yahoo! Finance]
2/25
11:42 am
adpt
Adaptive Biotechnologies: A Post Earnings Assessment [Seeking Alpha]
Medium
Report
Adaptive Biotechnologies: A Post Earnings Assessment [Seeking Alpha]
2/22
04:05 pm
adpt
Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference
Medium
Report
Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference
2/22
12:14 pm
adpt
In Vitro Diagnostics Markets Revolutionized by Artificial Intelligence and Multiplex Testing: A Comprehensive 2023-2027 Forecast [Yahoo! Finance]
Low
Report
In Vitro Diagnostics Markets Revolutionized by Artificial Intelligence and Multiplex Testing: A Comprehensive 2023-2027 Forecast [Yahoo! Finance]
2/16
01:36 pm
adpt
Adaptive Biotechnologies Co. (NASDAQ: ADPT) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $11.00 to $5.00. They now have a "neutral" rating on the stock.
Low
Report
Adaptive Biotechnologies Co. (NASDAQ: ADPT) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $11.00 to $5.00. They now have a "neutral" rating on the stock.
2/15
10:26 am
adpt
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/15
10:16 am
adpt
Adaptive Biotechnologies Co. (NASDAQ: ADPT) had its price target lowered by analysts at JPMorgan Chase & Co. from $11.00 to $8.00. They now have an "overweight" rating on the stock.
Medium
Report
Adaptive Biotechnologies Co. (NASDAQ: ADPT) had its price target lowered by analysts at JPMorgan Chase & Co. from $11.00 to $8.00. They now have an "overweight" rating on the stock.
2/14
05:24 pm
adpt
Adaptive Biotechnologies Corp (ADPT) Faces Revenue Decline Amid Growth in MRD Segment [Yahoo! Finance]
High
Report
Adaptive Biotechnologies Corp (ADPT) Faces Revenue Decline Amid Growth in MRD Segment [Yahoo! Finance]
2/14
04:23 pm
adpt
Adaptive Biotechnologies GAAP EPS of -$0.48 misses by $0.15, revenue of $45.78M misses by $2.68M [Seeking Alpha]
Medium
Report
Adaptive Biotechnologies GAAP EPS of -$0.48 misses by $0.15, revenue of $45.78M misses by $2.68M [Seeking Alpha]
2/14
04:18 pm
adpt
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
Low
Report
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
2/14
04:05 pm
adpt
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results
Low
Report
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results
2/13
02:40 am
adpt
Here's Why Adaptive Biotechnologies Corporation (ADPT) Declined in Q4 [Yahoo! Finance]
Medium
Report
Here's Why Adaptive Biotechnologies Corporation (ADPT) Declined in Q4 [Yahoo! Finance]